Incubator Weaning of Moderately Preterm Infants

March 20, 2019 updated by: NICHD Neonatal Research Network

Incubator Weaning of Moderately Preterm Infants: A Randomized Controlled Trial

The objective of this proposal is to evaluate whether weaning from an incubator to a crib at lower versus higher weight, 1600g or 1800g will result in shorter length of hospital stay among moderately preterm infants.

The hypothesis of this study is that length of hospital stay (from birth to discharge) will be decreased among moderate preterm infants weaned from an incubator to an open crib at a lower versus higher weight, 1600g vs. 1800g.

Study Overview

Study Type

Interventional

Enrollment (Actual)

366

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Alabama
      • Birmingham, Alabama, United States, 35233
        • University of Alabama at Birmingham
    • California
      • Los Angeles, California, United States, 90025
        • University of California - Los Angeles
      • Palo Alto, California, United States, 94304
        • Stanford University
    • Georgia
      • Atlanta, Georgia, United States, 30303
        • Emory University
    • Indiana
      • Indianapolis, Indiana, United States, 46202
        • Indiana University
    • Iowa
      • Iowa City, Iowa, United States, 52242
        • University of Iowa
    • Michigan
      • Detroit, Michigan, United States, 48201
        • Wayne State University
    • Missouri
      • Kansas City, Missouri, United States, 64108
        • Children's Mercy Hospital
    • New Mexico
      • Albuquerque, New Mexico, United States, 87131
        • University of New Mexico
    • New York
      • Rochester, New York, United States, 14642
        • University of Rochester
    • North Carolina
      • Durham, North Carolina, United States, 27710
        • Duke University
      • Durham, North Carolina, United States, 27705
        • RTI International
    • Ohio
      • Cincinnati, Ohio, United States, 45267
        • Cincinnati Children's Medical Center
      • Cleveland, Ohio, United States, 44106
        • Case Western Reserve University
      • Columbus, Ohio, United States, 43205
        • Research Institute at Nationwide Children's Hospital
    • Pennsylvania
      • Philadelphia, Pennsylvania, United States, 19104
        • Univeristy of Pennsylvania
    • Rhode Island
      • Providence, Rhode Island, United States, 02905
        • Brown University, Women & Infants Hospital of Rhode Island
    • Texas
      • Dallas, Texas, United States, 75235
        • University of Texas Southwestern Medical Center at Dallas

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

6 months to 7 months (CHILD)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Gestational age 29 0/7 to 33 6/7 weeks at birth
  • Birth weight less than 1600 grams
  • Greater than 48 hours of age
  • Current weight less than 1540 grams
  • In an incubator

Exclusion Criteria:

  • Receiving phototherapy
  • Receiving respiratory support (including CPAP, ventilation, HFNC > 2 LPM)
  • Receiving blood pressure support
  • Designated for transfer to referral hospital while in incubator
  • Known major congenital or chromosomal anomaly

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
ACTIVE_COMPARATOR: Lower Weight (1600 grams)
Weaning from an incubator at a lower weight (1600 grams)
Infants will be weaned from an incubator at a lower weight (1600 grams)
ACTIVE_COMPARATOR: Higher Weight (1800 grams)
Weaning from an incubator at a higher weight (1800 grams)
Infants will be weaned from an incubator at a higher weight (1800 grams)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Length of Hospital Stay (LOS) From Birth to Discharge (up to 120 Days)
Time Frame: From birth through discharge
Number of days the infant stays in hospital after birth until discharge home (up to 120 days).
From birth through discharge

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Length of Stay (LOS) Following Weaning From Incubator to Crib to Hospital Discharge (up to 120 Days)
Time Frame: From start of weaning from the incubator to crib through discharge (up to 120 days)
Among infants who were successfully weaned, the number of days in the hospital counting from the start of weaning from the incubator to the crib through discharge from the hospital (up to 120 days).
From start of weaning from the incubator to crib through discharge (up to 120 days)
Failure Rate of Weaning to Crib (Number of Infants With Axillary Temperature < 36.3°C After 2 Weaning Attempts)
Time Frame: Through completion of 2 weaning attempts
Failure of wean is defined as axillary temperature less than 36.3°C after one hour in the crib on 2 successive readings, 3 to 4 hours apart, within 24 hours of weaning to the crib in spite of additional clothes/coverings.
Through completion of 2 weaning attempts
Growth Velocity (Weight in Grams/kg/Day) From Start of Weaning From Incubator (Following Random Assignment) to 36 Weeks Postmenstrual Age (PMA)
Time Frame: Start of weaning from incubator through 36 weeks postmenstrual age (PMA)
Growth velocity in terms of weight (g/kg/day), considering infant weight at start of weaning from incubator to crib (following random assignment) and weight at 36 weeks postmenstrual age (PMA).
Start of weaning from incubator through 36 weeks postmenstrual age (PMA)
Growth Parameters: Weight at Status
Time Frame: Status (discharge, death, transfer to another facility, or 120 days)
Infant weight at status is measured at the time of discharge, death, transfer to another facility, or 120 days.
Status (discharge, death, transfer to another facility, or 120 days)
Growth Parameters: Length at Status
Time Frame: Status (discharge, death, transfer to another facility, or 120 days)
Infant length at status is measured at the time of discharge, death, transfer to another facility, or 120 days.
Status (discharge, death, transfer to another facility, or 120 days)
Growth Parameters: Head Circumference at Status
Time Frame: Status (discharge, death, transfer to another facility, or 120 days)
Infant head circumference at status is measured at the time of discharge, death, transfer to another facility, or 120 days.
Status (discharge, death, transfer to another facility, or 120 days)
Postmenstrual Age (PMA) at Discharge
Time Frame: Discharge
Postmenstrual age (PMA) at discharge is the sum of the gestational age of the infant and its length of stay in hospital from birth to discharge.
Discharge
Readmission to the Hospital Within 1 Week of Discharge
Time Frame: Discharge through 1 week after discharge.
Number of infants re-hospitalized within 1 week (7 days) of discharge.
Discharge through 1 week after discharge.
Death Among Enrolled Infants
Time Frame: Status (discharge, death, transfer to another facility, or 120 days)
Status (discharge, death, transfer to another facility, or 120 days)
Transferred to a Non-Network Hospital
Time Frame: Status (discharge, death, transfer to another facility, or 120 days)
Number of infants transferred to another non-Network hospital.
Status (discharge, death, transfer to another facility, or 120 days)
Length of Stay (LOS) Following Randomization to Hospital Discharge
Time Frame: From randomization through discharge.
The number of days the infant stayed in hospital after randomization to the study until discharge.
From randomization through discharge.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Brenda B Poindexter, MD, Indiana University
  • Principal Investigator: Abbot Laptook, MD, Brown University, Women & Infants Hosptial of Rhode Island
  • Principal Investigator: Kathleen A Kennedy, MD, The University of Texas Health Science Center, Houston
  • Principal Investigator: Mike Cotten, MD, Duke University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

February 1, 2015

Primary Completion (ACTUAL)

July 1, 2016

Study Completion (ACTUAL)

June 1, 2017

Study Registration Dates

First Submitted

May 8, 2014

First Submitted That Met QC Criteria

June 6, 2014

First Posted (ESTIMATE)

June 10, 2014

Study Record Updates

Last Update Posted (ACTUAL)

March 22, 2019

Last Update Submitted That Met QC Criteria

March 20, 2019

Last Verified

March 1, 2019

More Information

Terms related to this study

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Infant, Newborn

Clinical Trials on Weaning from an incubator at a lower weight (1600 grams)

Subscribe